반응식
[Cl:1][C:2]1[CH:15]=[CH:14][C:5]([CH2:6][CH2:7][N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)=[CH:4][CH:3]=1.[OH-].[K+].Br[CH2:19][CH2:20][CH2:21][Cl:22]>CS(C)=O>[ClH:1].[ClH:22].[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][CH2:7][N:8]2[CH2:13][CH2:12][N:11]([CH2:19][CH2:20][CH2:21][Cl:22])[CH2:10][CH2:9]2)=[CH:14][CH:15]=1참가 물질
5
실험 절차
The procedure described in Example 17(a) was followed, using 6.5 g of 1-(4-chlorophenethyl)piperazine, 6.0 g of potassium hydroxide, 125 ml of dimethyl sulfoxide and 4.6 g of 1-bromo-3-chloropropane. Work-up, as described above, gave 6.4 g (59% of theory) of 1-(4-chlorophenethyl)-4-(3-chloropropyl)piperazine dihydrochloride as a white crystalline solid.
출처 및 근거
- ORD 기록
- ord-3718907b4bb04353b2d6e7ee3e40a47d
- 출처 데이터셋
- uspto-grants-1988_02
- 특허 번호
- US04722926
연결된 노트
불러오는 중…